MKI67 and breast carcinoma: After 2013 St Gallen conference, Ki‐67 has been regarded as an important parameter for treatment decision.6 We hypothesized the definitions of subtypes including Ki‐67 index may outperform the previous classification without Ki‐67 value in predicting LRR for breast cancer undergo PMRT.